This inventor holds 12 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignee: University of Pittsburgh. Active years: 2018-2026.
Company Filing History:
Years Active: 2018-2026
Title: Jianhua Luo: Innovator in Cancer Treatment
Introduction
Jianhua Luo is a prominent inventor based in Wexford, PA (US), known for his significant contributions to cancer treatment through innovative methods. With a total of 12 patents, he has made remarkable strides in the field of genomic targeting and cancer therapy.
Latest Patents
Luo's latest patents include groundbreaking methods for treating cells containing fusion genes. One of his notable inventions focuses on treating patients with cancer or premalignant conditions by utilizing a genome editing technique that specifically targets fusion genes. This method has shown potential in inducing cell death in various cancer cells, including hepatocellular cancer cells. Another significant patent addresses the treatment of cancers associated with specific fusion genes, particularly highlighting the MAN2A1-FER fusion gene. This invention demonstrates the effectiveness of tyrosine kinase inhibitors in improving survival rates in animal models with cancers other than prostate cancer.
Career Highlights
Jianhua Luo is affiliated with the University of Pittsburgh, where he continues to advance research in cancer treatment. His work has garnered attention for its innovative approach to utilizing genomic techniques in the fight against cancer.
Collaborations
Luo collaborates with esteemed colleagues, including Joel Byron Nelson and George Michalopoulos, contributing to a dynamic research environment focused on cancer therapies.
Conclusion
Jianhua Luo's innovative work in cancer treatment through genomic targeting exemplifies the potential of modern medicine to address complex health challenges. His contributions are paving the way for new therapeutic strategies that could significantly impact patient outcomes.